Medgenics Inc

Type: Company

Name: Medgenics Inc

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Form 4 MEDGENICS, INC. For: Jun 03 Filed by: DELLIO CLARENCE L

StreetInsider.com - Form 4 MEDGENICS, INC. For: Jun 03 Filed by: DELLIO CLARENCE L ... [Published Street Insider - Jun 05 2013]

Entities: Medgenics Inc

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Medgenics Announces Results of 2013 Annual Meeting of Stockholders

Medgenics Inc. (NYSE MKT: MDGN and AIM: MEDU MEDG) (the “Company” or “Medgenics”)the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue today announces that all resolutions ... [Published PharmiWeb - May 24 2013]

Entities: Medgenics Inc, Hemophilia, biopsy, Stocks, anemia

First reported Feb 14 2013 - Updated Feb 14 2013 - 1 reports

The Jury Is Still Out On The Risky NS5B Drugs

By Ray Dirks : There has been some controversy over a recent article I posted discussing the hunt for new and better drugs to battle hepatitis C. A lot of this seemed to center on why one of the subjects of my story, Medgenics, Inc. (NASDAQ: MDGN ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 14 2013]

Entities: Drugs, Medgenics Inc, Hepatitis C

First reported Feb 01 2013 - Updated Feb 01 2013 - 1 reports

Medgenics begins phase 1/II trial in hepatitis to use Infradure tissue treatment

Medgenics, Inc., a developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, has enrolled its first patient in phase I/II clinical trial with the company’s Infradure ... [Published PharmaBiz - Feb 01 2013]

Entities: Medgenics Inc, Hepatitis, Hepatitis C

First reported Jan 30 2013 - Updated Jan 30 2013 - 1 reports

Medgenics Launches Trial For Multibillion-Dollar Holy Grail Indication Against Hepatitis C

BySharon di Stefano: The most critical period in a biotech company's life is the move from test tubes and mice to the clinic. Far fewer compounds than those investigated are allowed to go into humans because of meticulous regulation here and overseas, ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 30 2013]

Entities: Medgenics Inc, Hepatitis C, Clinical trials, Interferon, Hepatitis

More Content

sort by: Date \| Relevance
Market Movers - Top risers and fallers at 09:00 [Published MoneyAM - Jun 14 2013]
Form 4 MEDGENICS, INC. For: Jun 03 Filed by: DE... [Published Street Insider - Jun 05 2013]
Medgenics Announces Results of 2013 Annual Meet... [Published PharmiWeb - May 24 2013]
SECURITIES ACT REGISTRATIONS [Published Zecco - May 22 2013]
Medgenics Reports First Quarter 2013 Financial ... [Published Business Wire Professional Services News - May 09 2013]
Medgenics Reports First Quarter 2013 Financial ... [Published Business Wire Science: Science News - May 09 2013]
Medgenics Reports First Quarter 2013 Financial ... [Published Business Wire Health News - May 09 2013]
Medgenics Announces Results of 2013 Annual Meet... [Published Business Wire Science: Science News - May 01 2013]
Medgenics Announces Results of 2013 Annual Meet... [Published Business Wire Professional Services News - May 01 2013]
Medgenics Announces Results of 2013 Annual Meet... [Published Business Wire Health News - May 01 2013]
Medgenics Reports Positive Interim Results from... [Published Business Wire Health News - Apr 25 2013]
Medgenics Receives Notice of Allowance from the... [Published Business Wire Health News - Apr 22 2013]
Medgenics to Present at the 12th Annual Needham... [Published Business Wire Science: Science News - Apr 18 2013]
Medgenics to Present at the 12th Annual Needham... [Published Business Wire Health News - Apr 18 2013]
Medgenics Announces Exercise by Underwriters of... [Published Business Wire Health News - Mar 26 2013]
Medgenics to Present at the 25th Annual Roth Co... [Published Business Wire Health News - Mar 15 2013]
Medgenics Reports 2012 Financial Results [Published Business Wire Professional Services News - Mar 14 2013]
Medgenics Reports 2012 Financial Results [Published Business Wire Health News - Mar 14 2013]
Medgenics Appoints Former Chairman and CEO of U... [Published Business Wire Health News - Mar 12 2013]
The Jury Is Still Out On The Risky NS5B Drugs [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 14 2013]
Medgenics Announces Closing of Public Offering ... [Published EON Health & Medicine - Feb 14 2013]
Medgenics Announces Closing of Public Offering ... [Published Business Wire Professional Services News - Feb 14 2013]
Medgenics Announces Closing of Public Offering ... [Published Business Wire Health News - Feb 14 2013]
Medgenics Prices Public Offering of Common Stoc... [Published EON Health & Medicine - Feb 08 2013]
Medgenics Prices Public Offering of Common Stoc... [Published Business Wire Health News - Feb 08 2013]
Medgenics begins phase 1/II trial in hepatitis ... [Published PharmaBiz - Feb 01 2013]
Medgenics Launches Trial For Multibillion-Dolla... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 30 2013]
Medgenics Launches First Clinical Trial in Hepa... [Published EON Health & Medicine - Jan 30 2013]
Medgenics Launches First Clinical Trial in Hepa... [Published Business Wire Health News - Jan 30 2013]
Medgenics, Inc. (the “Company”) Issue of Option... [Published EON Health & Medicine - Jan 04 2013]